Palabras clave
Enfermedad de Alzheimer
Alimentación
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Describir los beneficios de la dieta que imita el ayuno en el tratamiento de la Enfermedad de Alzheimer. Revisión bibliográfica: La Enfermedad de Alzheimer es un trastorno neurodegenerativo, progresivo y multifactorial, caracterizado por el deterioro de las funciones cognitivas. En este contexto, destaca la dieta que imita el ayuno, conocida por su restricción calórica y la ingesta de alimentos exclusivamente a base de plantas, incluyendo niveles bajos de azúcar, proteínas y altos niveles de grasas insaturadas. Esta dieta tiene como objetivo reproducir los efectos del ayuno en un individuo que está comiendo. Sus efectos sobre el organismo ocurren a través de la activación de una vía metabólica alternativa, aportando beneficios notables como la reducción de la inflamación, la promoción de la autofagia y la limpieza celular, la reducción de la beta-amiloide, además de la disminución del estrés oxidativo. Consideraciones finales: La dieta que imita el ayuno contribuye a la mejora de la demencia causada por la Enfermedad de Alzheimer, indicando una posible opción de tratamiento.
Referencias
BOCCARDI V, et al. The Potential of Fasting-mimicking Diet as a Preventive and Curative Strategy for Alzheimer's Disease. Biomolecules, 2023; 13: 1133.
BRANDHORST S, et al. A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell Metabolism, 2015; 22: 86–99.
BRANDHORST S, et al. Fasting-mimicking diet causes hepatic and blood markers changes indicating reduced biological age and disease risk. Nature Communications, 2024; 15(1).
CALSOLARO V e EDISON P. Neuroinflammation in Alzheimer’s disease: Current evidence and future directions. Alzheimer’s & dementia: the journal of the Alzheimer’s Association, 2016; 12: 719–732.
CHOI IY, et al. Nutrition and fasting mimicking diets in the prevention and treatment of autoimmune diseases and immunosenescence. Molecular and Cellular Endocrinology, 2017; 455: 4–12.
DE GROOT S, et al. Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial. Nature communications, 2020; 11(1): 3083.
DENG Y, et al. Alzheimer’s disease with frailty: Prevalence, screening, assessment, intervention strategies and challenges. Bioscience trends, 2023; 17: 283–292.
GOURAS GK, et al. β-Amyloid peptides and amyloid plaques in Alzheimer’s disease. Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics, 2015; 12: 3–11.
GUTIERREZ BAO, et al. Economic impact of Alzheimer’s Disease in Brazil: is it possible to improve care and minimize costs? Ciência & Saúde Coletiva, 2014; 19: 4479–4486.
GRANT WB e BLAKE SM. Diet’s role in modifying risk of Alzheimer’s disease: History and present understanding. Journal of Alzheimer’s disease: JAD, 2023; 96(4): 1353–1382.
JIANG Z, et al. Effects of ketogenic diet on neuroinflammation in neurodegenerative diseases. Aging and Disease, 2022; 13(4): 1146.
KHAN S, et al. Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer’s disease. Current Neuropharmacology, 2022; 18: 1106–1125.
LEI P, et al. The essential elements of Alzheimer’s disease. The Journal of Biological Chemistry, 2020; 296: 1-28.
LI T, et al. Fasting-mimicking diet alleviates inflammatory pain by inhibiting neutrophil extracellular traps formation and neuroinflammation in the spinal cord. Cell communication and signaling: CCS, 2023; 21(1): 2-25.
LOBO F, et al. The effects of dietary interventions on brain aging and neurological diseases. Nutrients, 2022; 14: 5086.
LONGO V. The longevity diet: Slow aging, fight disease, optimize weight. Nova Iorque, NY, USA: Avery Publishing Group, 2019; 45p.
LONGO V, et al. Intermittent and periodic fasting, longevity and disease. Nature Aging, 2021; 1: 47–59.
MATTSON MP, et al. Impact of intermittent fasting on health and disease processes. Ageing research reviews, 2017; 39: 46–58.
PHILLIPS MCL. Fasting as a therapy in neurological disease. Nutrients, 2019; 11: 2501.
RANGAN P, et al. Fasting-mimicking diet cycles reduce neuroinflammation to attenuate cognitive decline in Alzheimer’s models. Cell reports, 2022; 40: 111417.
SCHELTENS P, et al. Alzheimer’s disease. Lancet, 2021; 397 1577–1590.
SOARES NM, et al. Economic impact and prevalence of Alzheimer’s disease in a Brazilian capital. Ciência & Saúde, 2017; 10: 133.
STRAC DS, et al. Personalizing the care and treatment of Alzheimer’s disease: An overview. Pharmacogenomics and Personalized Medicine, 2021; 14: 631-653.
TAHAMI MAA, et al. Alzheimer’s disease: Epidemiology and clinical progression. Neurology and Therapy, 2022; 11: 553–569.
ZHANG J, et al. Intermittent fasting protects against Alzheimer’s disease possibly through restoring aquaporin-4 polarity. Frontiers in Molecular Neuroscience, 2017; 10.
ZENG Z, et al. Fasting, a Potential Intervention in Alzheimer's Disease. Journal of Integrative Neuroscience, 2024; 23(3): 50.